MedTrace Logo

Ultrasound Guided Intermediate Cervical Plexus Block for Congenital Muscular Torticollis

NCT02651311 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2017-01-27

No results posted yet for this study

Summary

Congenital Muscular Torticollis (CMT) is a postural deformity of head and neck detected at birth or shortly after birth, primarily resulting from unilateral shortening of Sternocleidomastoid Muscle (SCM). Surgery could be chosen for the treatment for some children, which is accompanied by moderate pain and discomfort. The investigators focused the effectiveness of intermediates cervical plexus block because the dermatome of sensory of cervical plexus block is correlated to that of torticollis. So the effect of analgesia could decrease the use of analgesics.

Conditions

  • Congenital Muscular Torticollis

Interventions

OTHER

intermediate cervical plexus block

ultrasound guided intermediate cervical plexus block with 0.25% ropivacaine 0.2 ml/kg

DRUG

Fentanyl

fentanyl 0.5 µg/kg in postanesthetic care unit when more or equal to FLACC scale 4.

DRUG

Ibuprofen

ibuprofen in ward when more or equal to FLACC scale 4.

Sponsors & Collaborators

  • Ajou University School of Medicine

    lead OTHER

Principal Investigators

  • yun jeong chae, Ph.D · Ajou University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-16
Primary Completion
2016-12-15
Completion
2016-12-15

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02651311 on ClinicalTrials.gov